, Concernant l'éventuelle protection croisée induite par nos peptides, même si ces derniers sont conservés parmi les espèces de Leishmania, il est important d'élargir notre analyse à des individus immuns à des espèces de Leishmania autres que L. major
, Il serait également utile d'étudier le pouvoir immunogène des peptides dans des modèles expérimentaux animaux comme les souris transgéniques exprimant les allèles HLA et de déterminer ainsi la voie d'administration, la dose optimale et l'innocuité des peptides
, Une formulation idéale des peptides incluant leur conjugaison à des adjuvants devrait aussi être envisagée afin d'optimiser la réponse immunitaire
Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens, Proc Natl Acad Sci U S A, vol.100, issue.22, pp.12889-12894, 2003. ,
Proteome Data Sets: A Comprehensive Resource for Vaccine Development to Target Visceral Leishmaniasis, Front Immunol, vol.5, p.260, 2014. ,
Interactions with apoptotic but not with necrotic neutrophils increase parasite burden in human macrophages infected with Leishmania amazonensis, J Leukoc Biol, vol.84, issue.2, pp.389-396, 2008. ,
Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I-and II-Restricted Epitopes of Four Known Leishmania infantum Proteins, Front Immunol, vol.5, p.268, 2014. ,
Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis, Vaccine, vol.29, issue.31, pp.5053-5064, 2011. ,
Mucocutaneous leishmaniasis: an imported infection among travellers to central and South America, BMJ, vol.329, issue.7470, pp.842-844, 2004. ,
Epidemiological, clinical and biological features of infantile visceral leishmaniasis at Kairouan hospital (Tunisia): about 240 cases, Bull Soc Pathol Exot, vol.108, issue.4, pp.265-271, 2015. ,
Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection, Infect Immun, vol.68, issue.4, pp.1760-1764, 2000. ,
Demonstration of genetic exchange during cyclical development of Leishmania in the sand fly vector, Science, vol.324, issue.5924, pp.265-268, 2009. ,
Enumeration of human antigen-specific naive CD8+ T cells reveals conserved precursor frequencies, Blood, vol.115, issue.18, pp.3718-3725, 2010. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01402100
T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: is this paradigm still relevant?, Front Immunol, vol.3, p.80, 2012. ,
Leishmaniasis worldwide and global estimates of its incidence, PLoS One, vol.7, issue.5, p.35671, 2012. ,
, The F1F3, 2019.
, Recombinant Chimera of Leishmania donovani-Nucleoside Hydrolase (NH36) and Its Epitopes Induce Cross-Protection Against Leishmania (V.) braziliensis Infection in Mice, Front Immunol, vol.10, p.724
A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection, Front Immunol, vol.8, p.100, 2017. ,
A strategy for the identification of T-cell epitopes on Leishmania cysteine proteinases, Cytobios, vol.104, issue.405, pp.33-41, 2001. ,
Mucosal leishmaniasis . Current scenario and prospects for treatment, Acta Trop, vol.105, issue.1, pp.1-9, 2008. ,
,
Immunomodulation mediated through Leishmania donovani protein disulfide isomerase by eliciting CD8+ T-cell in cured visceral leishmaniasis subjects and identification of its possible HLA class-1 restricted T-cell epitopes, J Biomol Struct Dyn, vol.35, issue.1, pp.128-140, 2017. ,
CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis, J Exp Med, vol.204, issue.2, pp.285-297, 2007. ,
Endocytosis of an HIV-derived lipopeptide into human dendritic cells followed by class I-restricted CD8(+) T lymphocyte activation, Eur J Immunol, vol.30, issue.11, pp.3256-3265, 2000. ,
, , 2008.
results and analysis of the identification of 226 human and canine isolates, Bull Soc Pathol Exot, vol.101, issue.4, pp.323-328 ,
Cutaneous leishmaniasis in North Africa: a review, Parasite, vol.21, p.14, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01098542
Epidemiologic and parasitologic data concerning sporadic cutaneous leishmaniasis in northern Tunisia, Bull Soc Pathol Exot, vol.93, issue.2, pp.101-103, 2000. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01983309
, Med Mal Infect, vol.39, issue.10, pp.775-779, 2009.
Characterization of CD4(+) CTLs ex vivo, J Immunol, vol.168, issue.11, pp.5954-5958, 2002. ,
Field trial of a vaccine against New World cutaneous leishmaniasis in an at-risk child population: safety, immunogenicity, and efficacy during the first 12 months of follow-up, J Infect Dis, vol.177, issue.5, pp.1352-1357, 1998. ,
Field trial of a vaccine against new world cutaneous leishmaniasis in an at-risk child population: how long does protection last?, J Infect Dis, vol.187, issue.12, pp.1959-1961, 2003. ,
,
Cytotoxic CD4 T cells in viral hepatitis, J Viral Hepat, vol.13, issue.8, pp.505-514, 2006. ,
Peptide binding motifs and specificities for HLA-DQ molecules, Immunogenetics, vol.50, issue.1-2, pp.8-15, 1999. ,
Interleukin-12 restores interferon-gamma production and cytotoxic responses in visceral leishmaniasis, J Infect Dis, vol.173, issue.6, pp.1515-1518, 1996. ,
Up-regulation of Th1-type responses in mucosal leishmaniasis patients, Infect Immun, vol.70, issue.12, pp.6734-6740, 2002. ,
, , 2014.
, Nucleosomal histone proteins of L. donovani: a combination of recombinant H2A, vol.2, p.3
, H4 proteins were highly immunogenic and offered optimum prophylactic efficacy against Leishmania challenge in hamsters, PLoS One, vol.9, issue.6, p.97911
Functional Characterization of Monomeric GTPase Rab1 in the Secretory Pathway of Leishmania, J Biol Chem, vol.290, issue.50, pp.29993-30005, 2015. ,
Lipopeptides as immunoadjuvants and immunostimulants in mucosal immunization, Immunobiology, vol.201, issue.3-4, pp.391-405, 2000. ,
The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells, Proc Natl Acad Sci U S A, vol.91, issue.11, pp.4940-4944, 1994. ,
Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans, Adv Parasitol, vol.64, pp.1-109, 2007. ,
, Leishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis, vol.8, p.227, 2017.
Cytotoxicity in human mucosal and cutaneous leishmaniasis, Parasite Immunol, vol.17, issue.1, pp.21-28, 1995. ,
Lipids as activators of innate immunity in peptide vaccine delivery, Curr Med Chem, 2018. ,
Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1-and Th2-like responses in visceral leishmaniasis, J Immunol, vol.174, issue.11, pp.7160-7171, 2005. ,
HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages, J Infect Dis, vol.195, issue.9, pp.1373-1380, 2007. ,
Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies, Int J Parasitol, vol.37, issue.10, pp.1097-1106, 2007. ,
,
Surface glycoprotein PSA (GP46) expression during short-and long-term culture of Leishmania chagasi, Mol Biochem Parasitol, vol.131, issue.2, pp.109-117, 2003. ,
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity, Nature, vol.420, issue.6915, pp.502-507, 2002. ,
CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major, J Immunol, vol.168, issue.8, pp.3992-4000, 2002. ,
, , 2009.
, Visceral leishmaniasis in Tunisia: spatial distribution and association with climatic factors, Am J Trop Med Hyg, vol.81, issue.1, pp.40-45
Anti-leishmanial antibodies during natural infection of Psammomys obesus and Meriones shawi (Rodentia, Gerbillinae) by Leishmania major, Ann Soc Belg Med Trop, vol.69, issue.1, pp.35-40, 1989. ,
Epidemic cutaneous leishmaniasis in Tunisia: biochemical characterization of parasites, Trans R Soc Trop Med Hyg, vol.80, issue.4, pp.669-670, 1986. ,
Isolation of Leishmania major from Phlebotomus papatasi in Tunisia, Trans R Soc Trop Med Hyg, vol.81, issue.5, p.749, 1987. ,
,
The predictive validity of naturally acquired delayed-type hypersensitivity to leishmanin in resistance to Leishmania major-associated cutaneous leishmaniasis, J Infect Dis, vol.192, issue.11, pp.1981-1987, 2005. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00874052
,
Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells, Infect Immun, vol.73, issue.10, pp.6620-6628, 2005. ,
,
Leishmania antigens are presented to CD8+ T cells by a transporter associated with antigen processing-independent pathway in vitro and in vivo, J Immunol, vol.177, issue.6, pp.3525-3533, 2006. ,
Prevalence and determinants of Leishmania major infection in emerging and old foci in Tunisia, Parasit Vectors, vol.7, p.386, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01358530
KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major, Vaccine, vol.27, issue.9, pp.1306-1316, 2009. ,
Structure, function, and diversity of class I major histocompatibility complex molecules, Annu Rev Biochem, vol.59, pp.253-288, 1990. ,
Structure of the human class I histocompatibility antigen, HLA-A2, Nature, vol.329, issue.6139, pp.506-512, 1987. ,
Pathways of antigen processing, Annu Rev Immunol, vol.31, pp.443-473, 2013. ,
The role of nitric oxide in innate immunity, Immunol Rev, vol.173, pp.17-26, 2000. ,
Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amarante, RN), Vaccine, vol.20, pp.3277-3284, 2002. ,
Immunogenicity assay of the Leishmune vaccine against canine visceral leishmaniasis in Brazil, Vaccine, vol.26, issue.39, pp.4991-4997, 2008. ,
Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis, Infect Immun, vol.69, issue.5, pp.3232-3239, 2001. ,
Spread of Leishmania killicki to Central and South-West Tunisia, Parasite, vol.12, issue.1, pp.59-63, 2005. ,
Interleukin (IL)-13 is the predominant Th2 cytokine in localized cutaneous leishmaniasis lesions and renders specific CD4+ T cells unresponsive to IL-12, J Infect Dis, vol.183, issue.6, pp.953-959, 2001. ,
IL-10 producing CD8+ T cells in human infection with Leishmania guyanensis, Microbes Infect, vol.9, issue.8, pp.1034-1041, 2007. ,
Analysis of granzyme B activity as a surrogate marker of Leishmania-specific cell-mediated cytotoxicity in zoonotic cutaneous leishmaniasis, J Infect Dis, vol.189, issue.7, pp.1265-1273, 2004. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00875538
Epidemiologic and clinical features of cutaneous leishmaniasis in southeastern Tunisia, Am J Trop Med Hyg, vol.83, issue.5, pp.1034-1039, 2010. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00620980
Histological and immunological differences between zoonotic cutaneous leishmaniasis due to Leishmania major and sporadic cutaneous leishmaniasis due to Leishmania infantum, Parasite, vol.26, p.9, 2019. ,
Immunity Against Leishmania major Infection: Parasite-Specific Granzyme B Induction as a Correlate of Protection, Front Cell Infect Microbiol, vol.8, p.397, 2018. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02009502
,
Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum, Infect Genet Evol, vol.24, pp.1-14, 2014. ,
Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis, Infect Immun, vol.73, issue.10, pp.6372-6382, 2005. ,
Leishmaniasis, Lancet, vol.392, pp.951-970, 2018. ,
Enumeration and characterization of human memory T cells by enzyme-linked immunospot assays, Clin Dev Immunol, p.637649, 2013. ,
Design of a HIV-1-derived HLA-B07.02-restricted polyepitope construct, AIDS, vol.23, issue.15, pp.1945-1954, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00484766
Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice, J Exp Med, vol.183, issue.2, pp.515-526, 1996. ,
Immunologic response and memory T cells in subjects cured of tegumentary leishmaniasis, BMC Infect Dis, vol.13, p.529, 2013. ,
Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis, Parasite Immunol, vol.29, issue.5, pp.251-258, 2007. ,
Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production, Hum Immunol, vol.70, issue.6, pp.383-390, 2009. ,
HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity, J Immunol, vol.169, issue.12, pp.6928-6934, 2002. ,
Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins, Eur J Immunol, vol.37, issue.6, pp.1513-1523, 2007. ,
Hierarchy of CD4 T cell epitopes of the ANRS Lipo5 synthetic vaccine relies on the frequencies of pre-existing peptide-specific T cells in healthy donors, J Immunol, vol.190, issue.11, pp.5757-5763, 2013. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01109463
Characterization of the cellular immune response in American cutaneous leishmaniasis, Clin Immunol Immunopathol, vol.27, issue.2, pp.176-186, 1983. ,
, Ann Dermatol Venereol, vol.115, issue.12, pp.1255-1260, 1988.
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis, Vaccine, vol.29, pp.3531-3537, 2011. ,
,
,
In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis, PLoS One, vol.9, issue.5, p.92708, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01098532
Leishmania major large RAB GTPase is highly immunogenic in individuals immune to cutaneous and visceral leishmaniasis, Parasit Vectors, vol.10, issue.1, p.185, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01534742
Leishmanicidal mechanisms of human polymorphonuclear phagocytes, Am J Trop Med Hyg, vol.30, issue.2, pp.322-333, 1981. ,
Evolutionary comparison of prenylation pathway in kinetoplastid Leishmania and its sister Leptomonas, BMC Evol Biol, vol.15, p.261, 2015. ,
Identification of a new developmentally regulated Leishmania major large RAB GTPase, Biochem Biophys Res Commun, vol.341, issue.2, pp.541-548, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-01974057
Vaccination with the divergent portion of the protein histone H2B of Leishmania protects susceptible BALB/c mice against a virulent challenge with Leishmania major, Vaccine, vol.24, issue.14, pp.2521-2529, 2006. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02049467
An intense form of homeostatic proliferation of naive CD8+ cells driven by IL-2, J Exp Med, vol.204, issue.8, pp.1787-1801, 2007. ,
Could the lower frequency of CD8+CD18+CD45RO+ lymphocytes be biomarkers of human VL?, Int Immunol, vol.21, issue.2, pp.137-144, 2009. ,
Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells, Infect Immun, vol.75, issue.9, pp.4648-4654, 2007. ,
Human dendritic cell subsets, Immunology, vol.140, issue.1, pp.22-30, 2013. ,
Diffuse cutaneous leishmaniasis: a disease due to an immunological defect of the host, Trans R Soc Trop Med Hyg, vol.66, issue.4, pp.603-610, 1972. ,
Evolution of the genus Leishmania revealed by comparison of DNA and RNA polymerase gene sequences, Mol Biochem Parasitol, vol.89, issue.2, pp.149-159, 1997. ,
Plasticity in chromosome number and testing of essential genes in Leishmania by targeting, Proc Natl Acad Sci U S A, vol.90, issue.4, pp.1599-1603, 1993. ,
A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays, J Immunol Methods, vol.260, issue.1-2, pp.157-172, 2002. ,
Flow cytometric analysis of cellular infiltrate from American tegumentary leishmaniasis lesions, Br J Dermatol, vol.153, issue.3, pp.537-543, 2005. ,
T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy, Clin Diagn Lab Immunol, vol.9, issue.2, pp.251-256, 2002. ,
The Role of CD4 and CD8 T Cells in Human Cutaneous Leishmaniasis, Front Public Health, vol.2, p.165, 2014. ,
Gentamicin-attenuated Leishmania infantum vaccine: protection of dogs against canine visceral leishmaniosis in endemic area of southeast of Iran, PLoS Negl Trop Dis, vol.8, issue.4, p.2757, 2014. ,
,
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major, Nat Med, vol.13, issue.7, pp.843-850, 2007. ,
,
Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasis, Sci Transl Med, vol.6, issue.234, pp.234-256, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01375107
, Acta Haematol, vol.20, issue.1-4, pp.156-166, 1958.
Peptide Vaccines for Leishmaniasis, Front Immunol, vol.9, p.1043, 2018. ,
Effector memory CD4(+) T cells differentially express activation associated molecules depending on the duration of American cutaneous leishmaniasis lesions, Clin Exp Immunol, vol.185, issue.2, pp.202-209, 2016. ,
Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype, J Immunol, vol.154, issue.2, pp.685-693, 1995. ,
Characterizing cellular immune response to kinetoplastid membrane protein-11 (KMP-11) during Leishmania (Viannia) panamensis infection using dendritic cells (DCs) as antigen presenting cells (APCs), Parasite Immunol, vol.25, issue.4, pp.199-209, 2003. ,
The increase in risk factors for leishmaniasis worldwide, Trans R Soc Trop Med Hyg, vol.95, issue.3, pp.239-243, 2001. ,
Leishmaniasis: current situation and new perspectives, Comp Immunol Microbiol Infect Dis, vol.27, issue.5, pp.305-318, 2004. ,
The promastigote surface antigen gene family of the Leishmania parasite: differential evolution by positive selection and recombination, BMC Evol Biol, vol.8, p.292, 2008. ,
Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection, Blood, vol.90, issue.5, pp.1751-1767, 1997. ,
,
Vaccination with a CD4(+) and CD8(+) T-cell epitopes-based recombinant chimeric protein derived from Leishmania infantum proteins confers protective immunity against visceral leishmaniasis, Transl Res, vol.200, pp.18-34, 2018. ,
Inducible nitric oxide synthase and cytokine pattern in lesions of patients with American cutaneous leishmaniasis, Clin Exp Dermatol, vol.31, issue.1, pp.114-117, 2006. ,
Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite, Immunity, vol.8, issue.1, pp.77-87, 1998. ,
Vaccine potential of HLA-A2 epitopes from Leishmania Cysteine Protease Type III (CPC), Parasite Immunol, vol.39, issue.9, 2017. ,
The potential HLA Class I-restricted epitopes derived from LeIF and TSA of Leishmania donovani evoke anti-leishmania CD8+ T lymphocyte response, Sci Rep, vol.8, issue.1, p.14175, 2018. ,
Identification of Potential MHC Class-II-Restricted Epitopes Derived from Leishmania donovani Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T-Cell Responsiveness against Visceral Leishmaniasis, Front Immunol, vol.8, p.1763, 2017. ,
,
Mining the Proteome of Leishmania donovani for the Development of Novel MHC Class I Restricted Epitope for the Control of Visceral Leishmaniasis, J Cell Biochem, vol.119, issue.1, pp.378-391, 2018. ,
Mucocutaneous Leishmaniasis: clinical markers in presumptive diagnosis, Braz J Otorhinolaryngol, vol.77, issue.3, pp.380-384, 2011. ,
Leishmania development in sand flies: parasite-vector interactions overview, Parasit Vectors, vol.5, p.276, 2012. ,
In silico identification of supertypes for class II MHCs, J Immunol, vol.174, issue.11, pp.7085-7095, 2005. ,
Clinical safety of HIV lipopeptides used as vaccines in healthy volunteers and HIV-infected adults, AIDS, vol.20, issue.7, pp.1039-1049, 2006. ,
Polyfunctional T cell responses are a hallmark of HIV-2 infection, Eur J Immunol, vol.38, issue.2, pp.350-363, 2008. ,
Phenotypic and Functional Profiles of Antigen-Specific CD4(+) and CD8(+) T Cells Associated With Infection Control in Patients With Cutaneous Leishmaniasis, Front Cell Infect Microbiol, vol.8, p.393, 2018. ,
The contribution of the Fas/FasL apoptotic pathway in ulcer formation during Leishmania majorinduced cutaneous Leishmaniasis, Am J Pathol, vol.166, issue.4, pp.1099-1108, 2005. ,
Immunogenicity and immune modulatory effects of in silico predicted L. donovani candidate peptide vaccines, Hum Vaccin Immunother, vol.8, issue.12, pp.1769-1774, 2012. ,
Post-kala-azar dermal leishmaniasis in the Sudan: peripheral neural involvement, Int J Dermatol, vol.31, issue.6, pp.400-403, 1992. ,
Human memory T cells: generation, compartmentalization and homeostasis, Nat Rev Immunol, vol.14, issue.1, pp.24-35, 2014. ,
,
Recruitment of CD8(+) T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis, Parasite Immunol, vol.31, issue.8, pp.432-439, 2009. ,
Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein, Vaccine, vol.26, pp.5888-5895, 2008. ,
Antigenicity of Leishmania-Activated C-Kinase Antigen (LACK) in Human Peripheral Blood Mononuclear Cells, and Protective Effect of Prime-Boost Vaccination With pCI-neo-LACK Plus Attenuated LACK-Expressing Vaccinia Viruses in Hamsters, Front Immunol, vol.9, p.843, 2018. ,
,
IFN-gamma mediates the death of Th1 cells in a paracrine manner, J Immunol, vol.180, issue.2, pp.842-849, 2008. ,
Dichotomy of the T cell response to Leishmania antigens in patients suffering from cutaneous leishmaniasis; absence or scarcity of Th1 activity is associated with severe infections, Clin Exp Immunol, vol.100, issue.2, pp.239-245, 1995. ,
Multiepitopic B-and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine, J Virol, vol.74, issue.4, pp.1694-1703, 2000. ,
Serum cytokine profile in the subclinical form of visceral leishmaniasis, Braz J Med Biol Res, vol.37, issue.1, pp.129-136, 2004. ,
The genus Leishmania, Bull World Health Organ, vol.44, issue.4, pp.477-489, 1971. ,
Mucosal leishmaniasis patients display an activated inflammatory T-cell phenotype associated with a nonbalanced monocyte population, Scand J Immunol, vol.63, issue.1, pp.70-78, 2006. ,
Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus, Nat Immunol, vol.10, issue.5, pp.524-530, 2009. ,
Médecine tropicale -6e édition Book, 2012. ,
A randomized placebocontrolled phase Ia malaria vaccine trial of two virosome-formulated synthetic peptides in healthy adult volunteers, PLoS One, vol.2, issue.10, p.1018, 2007. ,
Status of vaccine research and development of vaccines for leishmaniasis, Vaccine, vol.34, issue.26, pp.2992-2995, 2016. ,
Memory T cells in cutaneous leishmaniasis, Cell Immunol, vol.309, pp.50-54, 2016. ,
Skin-resident CD4+ T cells protect against Leishmania major by recruiting and activating inflammatory monocytes, PLoS Pathog, vol.13, issue.4, p.1006349, 2017. ,
Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection, J Exp Med, vol.212, issue.9, pp.1405-1414, 2015. ,
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study, Lancet, vol.386, issue.9995, pp.743-800, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01285498
Insights into CD4+ memory T cells following Leishmania infection, Trends Parasitol, vol.21, issue.8, pp.347-350, 2005. ,
Immunoregulation in human American leishmaniasis: balancing pathology and protection, Parasite Immunol, vol.36, issue.8, pp.367-376, 2014. ,
IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection, PLoS Pathog, vol.9, issue.3, p.1003243, 2013. ,
A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma, J Surg Res, vol.63, issue.1, pp.298-304, 1996. ,
Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes, Immunogenetics, vol.63, issue.6, pp.325-335, 2011. ,
The present and future of vaccination for cutaneous leishmaniasis, Prog Clin Biol Res, vol.47, pp.259-285, 1980. ,
A review of the geographic distribution and epidemiology of leishmaniasis in the New World, Am J Trop Med Hyg, vol.41, issue.6, pp.687-725, 1989. ,
Trafficking of Leishmania donovani promastigotes in non-lytic compartments in neutrophils enables the subsequent transfer of parasites to macrophages, Cell Microbiol, vol.10, issue.1, pp.100-111, 2008. ,
,
An in silico immunological approach for prediction of CD8+ T cell epitopes of Leishmania major proteins in susceptible BALB/c and resistant C57BL/6 murine models of infection, Infect Genet Evol, vol.9, issue.3, pp.344-350, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-01973331
ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells, Nature, vol.425, issue.6956, pp.397-402, 2003. ,
Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon, PLoS Negl Trop Dis, vol.5, issue.3, p.980, 2011. ,
Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps, Proc Natl Acad Sci U S A, vol.106, issue.16, pp.6748-6753, 2009. ,
Innate immunity against Leishmania infections, Cell Microbiol, vol.17, issue.9, pp.1286-1294, 2015. ,
Correlation between histopathology, immune response, clinical presentation, and evolution in Leishmania braziliensis infection, Am J Trop Med Hyg, vol.45, issue.3, pp.281-289, 1991. ,
Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors, Front Immunol, vol.8, p.500, 2017. ,
Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response, Infect Immun, vol.63, issue.11, pp.4261-4267, 1995. ,
Diffuse and disseminated cutaneous leishmaniasis: clinical cases experienced in Ecuador and a brief review, Trop Med Health, vol.44, issue.2, 2016. ,
Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets, J Exp Med, vol.169, issue.1, pp.59-72, 1989. ,
T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation, Nat Immunol, vol.9, issue.3, pp.282-291, 2008. ,
CD8 cells of patients with diffuse cutaneous leishmaniasis display functional exhaustion: the latter is reversed, in vitro, by TLR2 agonists, PLoS Negl Trop Dis, vol.4, issue.11, p.871, 2010. ,
The present status and future prospects of peptidebased cancer vaccines, Int Immunol, vol.28, issue.7, pp.319-328, 2016. ,
,
Potential role for interleukin-10 in the immunosuppression associated with kala azar, J Clin Invest, vol.92, issue.6, pp.2626-2632, 1993. ,
Regulatory T-cell profile in early and late lesions of cutaneous leishmaniasis due to Leishmania major, J Res Med Sci, vol.17, issue.6, pp.513-518, 2012. ,
Phagosomes are competent organelles for antigen cross-presentation, Nature, vol.425, issue.6956, pp.402-406, 2003. ,
IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins, Immunity, vol.24, issue.5, pp.563-574, 2006. ,
Effective and longlasting immunity against the parasite Leishmania major in CD8-deficient mice, Infect Immun, vol.66, issue.8, pp.3968-3970, 1998. ,
Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis, Vaccine, vol.22, pp.3865-3876, 2004. ,
Cationic liposomes formulated with a novel whole Leishmania lysate (WLL) as a vaccine for leishmaniasis in murine model, Immunobiology, vol.223, issue.6-7, pp.493-500, 2018. ,
Immunoprotective Leishmania major synthetic T cell epitopes, J Exp Med, vol.172, issue.2, pp.645-648, 1990. ,
Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity, Nature, vol.483, issue.7388, pp.227-231, 2012. ,
Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of Leishmania (Leishmania) donovani, Front Immunol, vol.10, p.288, 2019. ,
,
Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guerrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers, Trans R Soc Trop Med Hyg, vol.97, issue.3, pp.365-368, 2003. ,
,
Protein biomarkers discriminate Leishmania major-infected and non-infected individuals in areas endemic for cutaneous leishmaniasis, BMC Infect Dis, vol.16, p.138, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01358493
The role of IL-10 in promoting disease progression in leishmaniasis, J Immunol, vol.166, issue.2, pp.1141-1147, 2001. ,
Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines, J Virol, vol.81, issue.21, pp.12071-12076, 2007. ,
Evaluation of cellular immunological responses in mono-and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India, Clin Exp Immunol, vol.185, issue.1, pp.50-60, 2016. ,
Role of CD8(+) T cells in protection against Leishmania donovani infection in healed Visceral Leishmaniasis individuals, BMC Infect Dis, vol.14, p.653, 2014. ,
Visceral leishmaniasis: immunology and prospects for a vaccine, Clin Microbiol Infect, vol.17, issue.10, pp.1462-1470, 2011. ,
,
Induction of protective CD4+ T cell-mediated immunity by a Leishmania peptide delivered in recombinant influenza viruses, PLoS One, vol.7, issue.3, p.33161, 2012. ,
,
A leucine-rich repeat motif of Leishmania parasite surface antigen 2 binds to macrophages through the complement receptor 3, J Immunol, vol.172, issue.8, pp.4902-4906, 2004. ,
The Leishmania promastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity to L. major, FEMS Immunol Med Microbiol, vol.20, issue.3, pp.209-218, 1998. ,
Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis, Clin Exp Immunol, vol.96, issue.3, pp.410-415, 1994. ,
Interferon-gamma and interleukin-4 in human Leishmania donovani infections, Immunol Cell Biol, vol.71, pp.583-587, 1993. ,
CCR7+ central and CCR7-effector memory CD4+ T cells in human cutaneous leishmaniasis, J Clin Immunol, vol.33, issue.1, pp.220-234, 2013. ,
Phenotyping of circulating CD8(+) T cell subsets in human cutaneous leishmaniasis, Microbes Infect, vol.14, issue.9, pp.702-711, 2012. ,
DNA vaccines: roles against diseases, Germs, vol.3, issue.1, pp.26-35, 2013. ,
The nucleosome: from genomic organization to genomic regulation, Cell, vol.116, issue.2, pp.259-272, 2004. ,
Presentation via the class I pathway by Leishmania amazonensis-infected macrophages of an endogenous leishmanial antigen to CD8+ T cells, J Immunol, vol.159, issue.4, pp.1828-1834, 1997. ,
Interferon gamma in leishmaniasis, Front Immunol, vol.4, p.156, 2013. ,
IL-4-deficient Balb/c mice resist infection with Leishmania major, J Exp Med, vol.184, issue.3, pp.1127-1136, 1996. ,
DNA vaccine against visceral leishmaniasis: a promising approach for prevention and control, Parasite Immunol, vol.38, issue.5, pp.273-281, 2016. ,
T cell suppression in the bone marrow of visceral leishmaniasis patients: impact of parasite load, Clin Exp Immunol, vol.191, issue.3, pp.318-327, 2018. ,
Multiplex analysis of circulating cytokines in the sera of patients with different clinical forms of visceral leishmaniasis, Cytometry A, vol.69, issue.5, pp.353-358, 2006. ,
The Immunology of a Healing Response in Cutaneous Leishmaniasis Treated with Localized Heat or Systemic Antimonial Therapy, PLoS Negl Trop Dis, vol.9, issue.10, p.4178, 2015. ,
Understanding the generation and function of memory T cell subsets, Curr Opin Immunol, vol.17, issue.3, pp.326-332, 2005. ,
Neutrophil granulocytes--Trojan horses for Leishmania major and other intracellular microbes?, Trends Microbiol, vol.11, issue.5, pp.210-214, 2003. ,
Neutrophil granulocytes as host cells and transport vehicles for intracellular pathogens: apoptosis as infection-promoting factor, Immunobiology, vol.213, issue.3-4, pp.183-191, 2008. ,
Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial, PLoS One, vol.2, issue.8, p.725, 2007. ,
Asymptomatic dogs are highly competent to transmit Leishmania (Leishmania) infantum chagasi to the natural vector, Vet Parasitol, vol.196, issue.3-4, pp.296-300, 2013. ,
Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes, Vaccine, vol.23, issue.22, pp.2825-2840, 2005. ,
Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial, Vaccine, vol.25, issue.21, pp.4223-4234, 2007. ,
A melanoma multiepitope polypeptide induces specific CD8+ T-cell response, Cell Immunol, vol.250, issue.1-2, pp.24-30, 2007. ,
Polyfunctional CD4(+) T Cells As Targets for Tuberculosis Vaccination, Front Immunol, vol.8, p.1262, 2017. ,
Peptide Vaccine: Progress and Challenges, Vaccines (Basel), vol.2, issue.3, pp.515-536, 2014. ,
Tumour necrosis factor (TNF alpha) in leishmaniasis. I. TNF alpha mediates host protection against cutaneous leishmaniasis, Immunology, vol.69, issue.4, pp.570-573, 1990. ,
How Can Elispot Add Information to Improve Knowledge on Tropical Diseases, Cells, vol.6, issue.4, 2017. ,
COMPASS identifies T-cell subsets correlated with clinical outcomes, Nat Biotechnol, vol.33, issue.6, pp.610-616, 2015. ,
Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells, J Immunol, vol.182, issue.12, pp.8047-8055, 2009. ,
The early interaction of Leishmania with macrophages and dendritic cells and its influence on the host immune response, Front Cell Infect Microbiol, vol.2, p.83, 2012. ,
The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection, J Immunol, vol.159, issue.3, pp.1383-1392, 1997. ,
,
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasis, Vaccine, vol.28, pp.7427-7435, 2010. ,
Extension of HLA-A*0201-restricted minimal epitope by N epsilonpalmitoyl-lysine increases the life span of functional presentation to cytotoxic T cells, J Immunol, vol.164, issue.2, pp.900-907, 2000. ,
Leishmania mexicana promastigotes induce cytotoxic T lymphocytes in vivo that do not recognize infected macrophages, Eur J Immunol, vol.23, issue.1, pp.217-223, 1993. ,
IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice, J Immunol, vol.182, issue.5, pp.3039-3046, 2009. ,
Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major, J Infect Dis, vol.177, issue.6, pp.1687-1695, 1998. ,
Definition of supertypes for HLA molecules using clustering of specificity matrices, Immunogenetics, vol.55, issue.12, pp.797-810, 2004. ,
A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition, J Exp Med, vol.198, issue.5, pp.679-691, 2003. ,
, , 2012.
, Multifunctional CD4(+) T cells in patients with American cutaneous leishmaniasis, Clin Exp Immunol, vol.167, issue.3, pp.505-513
Reappraisal of the immunopathogenesis of disseminated leishmaniasis: in situ and systemic immune response, Trans R Soc Trop Med Hyg, vol.105, issue.8, pp.438-444, 2011. ,
Transcriptome patterns from primary cutaneous Leishmania braziliensis infections associate with eventual development of mucosal disease in humans, PLoS Negl Trop Dis, vol.6, issue.9, p.1816, 2012. ,
Batf3-dependent CD103+ dendritic cells are major producers of IL-12 that drive local Th1 immunity against Leishmania major infection in mice, Eur J Immunol, vol.45, issue.1, pp.119-129, 2015. ,
A recombinant chimeric protein composed of human and mice-specific CD4(+) and CD8(+) T-cell epitopes protects against visceral leishmaniasis, Parasite Immunol, vol.39, issue.1, 2017. ,
Control of Leishmania infantum infection is associated with CD8(+) and gamma interferon-and interleukin-5-producing CD4(+) antigen-specific T cells, Infect Immun, vol.67, issue.11, pp.5559-5566, 1999. ,
Preferential localization of effector memory cells in nonlymphoid tissue, Science, vol.291, issue.5512, pp.2413-2417, 2001. ,
Potency, efficacy and durability of DNA/DNA, DNA/protein and protein/protein based vaccination using gp63 against Leishmania donovani in BALB/c mice, PLoS One, vol.6, issue.2, p.14644, 2011. ,
Cellular and humoral responses induced by Leishmania histone H2B and its divergent and conserved parts in cutaneous and visceral leishmaniasis patients, respectively, Vaccine, vol.28, issue.7, pp.1881-1886, 2010. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00621005
Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?, AIDS, vol.6, issue.12, pp.1499-1503, 1992. ,
Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis, Infect Immun, vol.62, issue.3, pp.837-842, 1994. ,
Novel insights into the HLA class I immunopeptidome and T-cell immunosurveillance, Genome Med, vol.9, issue.1, p.44, 2017. ,
T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases, Nature, vol.427, issue.6970, pp.154-159, 2004. ,
Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity, J Exp Med, vol.200, issue.2, pp.201-210, 2004. ,
A role for IgG immune complexes during infection with the intracellular pathogen Leishmania, J Exp Med, vol.201, issue.5, pp.747-754, 2005. ,
Differences between IL-4-and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling, J Immunol, vol.162, issue.12, pp.7302-7308, 1999. ,
,
Infectivity of dogs naturally infected with Leishmania infantum to colonized Phlebotomus perniciosus, Trans R Soc Trop Med Hyg, vol.88, issue.4, pp.491-493, 1994. ,
Selective fusion of azurophilic granules with Leishmania-containing phagosomes in human neutrophils, J Biol Chem, vol.285, issue.45, pp.34528-34536, 2010. ,
,
Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude, Immunity, vol.27, issue.2, pp.203-213, 2007. ,
Identification of broadly conserved cross-species protective Leishmania antigen and its responding CD4+ T cells, Sci Transl Med, vol.7, issue.310, pp.310-167, 2015. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01375023
Self-adjuvanting lipopeptide vaccines, Curr Med Chem, vol.15, issue.5, pp.506-516, 2008. ,
Role of T cell subsets during the recall of immunologic memory to Leishmania major, Eur J Immunol, vol.22, issue.12, pp.3063-3069, 1992. ,
, , 2002.
, Toxicity, immunogenicity, and induction of E75-specific tumor-lytic CTLs by HER-2 peptide E75 (369-377) combined with granulocyte macrophage colony-stimulating factor in HLA-A2+ patients with metastatic breast and ovarian cancer, Clin Cancer Res, vol.8, issue.11, pp.3407-3418
Involvement of different CD4(+) T cell subsets producing granzyme B in the immune response to Leishmania major antigens, Mediators Inflamm, p.636039, 2014. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01059851
Prediction of T Cell Epitopes from Leishmania major Potentially Excreted/Secreted Proteins Inducing Granzyme B Production, PLoS One, vol.11, issue.1, p.147076, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01356501
The past decade in malaria synthetic peptide vaccine clinical trials, Hum Vaccin, vol.6, issue.1, pp.27-38, 2010. ,
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis, Vaccine, vol.28, issue.40, pp.6581-6587, 2010. ,
Interleukin 17A acts synergistically with interferon gamma to promote protection against Leishmania infantum infection, J Infect Dis, vol.211, issue.6, pp.1015-1026, 2015. ,
CD8+ T cells as a source of IFN-gamma production in human cutaneous leishmaniasis, PLoS Negl Trop Dis, vol.4, issue.10, p.845, 2010. ,
,
, Differential in vitro CD4+/CD8+, 2010.
, T-cell response to live vs. killed Leishmania major, Parasite Immunol, vol.32, issue.2, pp.101-110
Towards a systems understanding of MHC class I and MHC class II antigen presentation, Nat Rev Immunol, vol.11, issue.12, pp.823-836, 2011. ,
Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal Domains, Front Immunol, vol.5, p.189, 2014. ,
IL-4-and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains, J Immunol, vol.162, issue.10, pp.6132-6140, 1999. ,
Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis, PLoS Pathog, vol.9, issue.7, p.1003504, 2013. ,
Genomic profiling of human Leishmania braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathology, J Invest Dermatol, vol.135, issue.1, pp.94-101, 2015. ,
CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly, Semin Immunopathol, vol.37, issue.3, pp.251-259, 2015. ,
A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program, Drugs, vol.74, issue.1, pp.15-30, 2014. ,
Protective immunity and vaccination against cutaneous leishmaniasis, Front Immunol, vol.3, p.128, 2012. ,
CD8+ T cells are preferentially activated during primary low dose leishmania major infection but are completely dispensable during secondary anti-Leishmania immunity, PLoS Negl Trop Dis, vol.8, issue.11, p.3300, 2014. ,
A randomised, double-blind, controlled efficacy trial of the LiESP/QA-21 vaccine in naive dogs exposed to two leishmania infantum transmission seasons, PLoS Negl Trop Dis, vol.8, issue.10, p.3213, 2014. ,
Lesion size correlates with Leishmania antigen-stimulated TNF-levels in human cutaneous leishmaniasis, Am J Trop Med Hyg, vol.85, issue.1, pp.70-73, 2011. ,
,
A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates, Sci Transl Med, vol.7, issue.290, pp.290-290, 2015. ,
Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial, Infect Immun, vol.73, issue.6, pp.3587-3597, 2005. ,
Worldwide risk factors in leishmaniasis, Asian Pac J Trop Med, vol.9, issue.10, pp.925-932, 2016. ,
A new categorization of HLA DR alleles on a functional basis, Hum Immunol, vol.59, issue.10, pp.665-676, 1998. ,
IgG and IgG subclass antibodies in patients with active cutaneous leishmaniasis, J Med Microbiol, vol.55, pp.1329-1331, 2006. ,
The central memory CD4+ T cell population generated during Leishmania major infection requires IL-12 to produce IFN-gamma, J Immunol, vol.180, issue.12, pp.8299-8305, 2008. ,
Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells, Eur J Immunol, vol.19, issue.12, pp.2237-2242, 1989. ,
,
,
Comparative genomic analysis of three Leishmania species that cause diverse human disease, Nat Genet, vol.39, issue.7, pp.839-847, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-00169316
Clinical spectrum of Leishmaniasis, Clin Infect Dis, vol.22, issue.1, pp.1-13, 1996. ,
,
Clinical trial results of a HER2/neu (E75) vaccine to prevent recurrence in high-risk breast cancer patients, J Clin Oncol, vol.23, issue.30, pp.7536-7545, 2005. ,
Leishmania braziliensis-reactive T cells are down-regulated in long-term cured cutaneous Leishmaniasis, but the renewal capacity of T effector memory compartments is preserved, PLoS One, vol.8, issue.11, p.81529, 2013. ,
,
In silico predicted epitopes from the COOH-terminal extension of cysteine proteinase B inducing distinct immune responses during Leishmania (Leishmania) amazonensis experimental murine infection, BMC Immunol, vol.12, p.44, 2011. ,
Increase of NK cells and proinflammatory monocytes are associated with the clinical improvement of diffuse cutaneous leishmaniasis after immunochemotherapy with BCG/Leishmania antigens, Am J Trop Med Hyg, vol.81, issue.3, pp.378-383, 2009. ,
In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies, Science, vol.321, issue.5891, pp.970-974, 2008. ,
Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs, PLoS Negl Trop Dis, vol.10, issue.5, p.4614, 2016. ,
URL : https://hal.archives-ouvertes.fr/ird-01321775
Vaccine adjuvants: current state and future trends, Immunol Cell Biol, vol.82, issue.5, pp.488-496, 2004. ,
Editorial: Cytotoxic CD4+ T Cells in Viral Infections, Front Immunol, vol.8, p.1729, 2017. ,
IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani, J Clin Invest, vol.119, issue.8, pp.2379-2387, 2009. ,
High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals, J Exp Med, vol.190, issue.5, pp.705-715, 1999. ,
Leishmania and the macrophage: a multifaceted interaction, Future Microbiol, vol.10, issue.1, pp.111-129, 2015. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01123316
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge, PLoS Negl Trop Dis, vol.11, issue.12, p.6052, 2017. ,
Monoclonal antibodies that distinguish between New World species of Leishmania, Nature, vol.291, issue.5816, pp.581-583, 1981. ,
Duration of the initial TCR stimulus controls the magnitude but not functionality of the CD8+ T cell response, J Exp Med, vol.203, issue.9, pp.2135-2143, 2006. ,
More than one reason to rethink the use of peptides in vaccine design, Nat Rev Drug Discov, vol.6, issue.5, pp.404-414, 2007. ,
Rab5 Isoforms Specifically Regulate Different Modes of Endocytosis in Leishmania, J Biol Chem, vol.291, issue.28, pp.14732-14746, 2016. ,
Characterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy, Infect Immun, vol.72, issue.2, pp.863-870, 2004. ,
Leishmaniasis emergence in Europe, Euro Surveill, vol.15, issue.10, p.19505, 2010. ,
Epidemiology of visceral leishmaniasis, Clin Epidemiol, vol.6, pp.147-154, 2014. ,
,
A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease, Nat Med, vol.10, issue.4, pp.406-410, 2004. ,
Key roles of adjuvants in modern vaccines, Nat Med, vol.19, issue.12, pp.1597-1608, 2013. ,
Field randomized trial to evaluate the efficacy of the Leish-Tec(R) vaccine against canine visceral leishmaniasis in an endemic area of Brazil, Vaccine, vol.34, pp.2233-2239, 2016. ,
The regulation of immunity to Leishmania major, Annu Rev Immunol, vol.13, pp.151-177, 1995. ,
Evolutionarily conserved proteins as prominent immunogens during Leishmania infections, Parasitol Today, vol.16, issue.6, pp.246-250, 2000. ,
Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-gamma and cytolytic activity by CD8+ T cells, Vaccine, vol.26, issue.35, pp.4585-4593, 2008. ,
Immunogenicity of MHC Class I Peptides Derived from Leishmania mexicana Gp63 in HLA-A2.1 Transgenic (HHDII) and BALB/C Mouse Models, Iran J Parasitol, vol.7, issue.4, pp.27-40, 2012. ,
Histological analysis and the pathogenesis of mucocutaneous leishmaniasis, J Pathol, vol.159, issue.4, pp.293-299, 1989. ,
Isolation of Leishmania major Yakimoff and Shokhor, 1914 (Kinetoplastida-Trypanosomatidae) in Meriones shawi-shawi (Duvernoy, 1842) (Rodentia-Gerbillidae) in Tunisia, Ann Parasitol Hum Comp, vol.61, issue.2, pp.139-145, 1986. ,
The control of Leishmania (Leishmania) major by TNF in vivo is dependent on the parasite strain, Microbes Infect, vol.6, issue.6, pp.559-565, 2004. ,
Leishmania-host-cell interaction: complexities and alternative views, Parasitol Today, vol.16, issue.7, pp.292-297, 2000. ,
Vaccine development against cutaneous leishmaniasis. Subcutaneous administration of radioattenuated parasites protects CBA mice against virulent Leishmania major challenge, Parasite Immunol, vol.15, issue.2, pp.75-84, 1993. ,
Present Yourself! By MHC Class I and MHC Class II Molecules, Trends Immunol, vol.37, issue.11, pp.724-737, 2016. ,
Cross-presentation: underlying mechanisms and role in immune surveillance, Immunol Rev, vol.207, pp.166-183, 2005. ,
Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells, Nat Cell Biol, vol.1, issue.6, pp.362-368, 1999. ,
,
Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or AS02, PLoS One, vol.3, issue.12, p.3960, 2008. ,
How to master the host immune system? Leishmania parasites have the solutions!, Int Immunol, vol.30, issue.3, pp.103-111, 2018. ,
Everything you always wanted to know about sex (but were afraid to ask)" in Leishmania after two decades of laboratory and field analyses, PLoS Pathog, vol.6, issue.8, p.1001004, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-02401702
,
Enzyme-linked immunosorbent assay based on soluble promastigote antigen detects immunoglobulin M (IgM) and IgG antibodies in sera from cases of visceral and cutaneous leishmaniasis, J Clin Microbiol, vol.40, issue.3, pp.1037-1043, 2002. ,
Immunogenicity and efficacy of single antigen Gp63, polytope and polytopeHSP70 DNA vaccines against visceral Leishmaniasis in experimental mouse model, PLoS One, vol.4, issue.12, p.7880, 2009. ,
The immunology of susceptibility and resistance to Leishmania major in mice, Nat Rev Immunol, vol.2, issue.11, pp.845-858, 2002. ,
Computational analysis of cysteine proteases (Clan CA, Family Cl) of Leishmania major to find potential epitopic regions, Genomics Proteomics Bioinformatics, vol.7, issue.3, pp.87-95, 2009. ,
IL-10-and TGF-betamediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India, J Immunol, vol.179, issue.8, pp.5592-5603, 2007. ,
Zoonotic cutaneous leishmaniasis in central Tunisia: spatio temporal dynamics, Int J Epidemiol, vol.36, issue.5, pp.991-1000, 2007. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00871665
Treatment of two patients with diffuse cutaneous leishmaniasis caused by Leishmania mexicana modifies the immunohistological profile but not the disease outcome, Trop Med Int Health, vol.4, issue.12, pp.801-811, 1999. ,
Central memory and effector memory T cell subsets: function, generation, and maintenance, Annu Rev Immunol, vol.22, pp.745-763, 2004. ,
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions, Nature, vol.401, issue.6754, pp.708-712, 1999. ,
Immune response regulation by leishmania secreted and nonsecreted antigens, J Biomed Biotechnol, issue.6, p.85154, 2007. ,
, , 2013.
, IFNgamma(+)-mediated parasite killing in human cutaneous leishmaniasis, J Invest Dermatol, vol.133, issue.6, pp.1533-1540
Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia, Clin Exp Immunol, vol.116, issue.1, pp.127-132, 1999. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00878412
Cutaneous Manifestations of Human and Murine Leishmaniasis, Int J Mol Sci, vol.18, issue.6, 2017. ,
The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development, Immunol Rev, vol.201, pp.318-338, 2004. ,
Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens, J Exp Med, vol.168, issue.5, pp.1675-1684, 1988. ,
Cutaneous leishmaniasis: immune responses in protection and pathogenesis, Nat Rev Immunol, vol.16, issue.9, pp.581-592, 2016. ,
Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease, Immunol Rev, vol.112, pp.161-182, 1989. ,
T-cell quality in memory and protection: implications for vaccine design, Nat Rev Immunol, vol.8, issue.4, pp.247-258, 2008. ,
Optimizing vaccine design for cellular processing, MHC binding and TCR recognition, vol.59, pp.443-451, 2002. ,
Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism, Immunogenetics, vol.50, issue.3-4, pp.201-212, 1999. ,
Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccine, PLoS One, vol.9, issue.10, p.108848, 2014. ,
In silico analysis of six known Leishmania major antigens and in vitro evaluation of specific epitopes eliciting HLA-A2 restricted CD8 T cell response, PLoS Negl Trop Dis, vol.5, issue.9, p.1295, 2011. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00787351
Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis, Vaccine, vol.30, issue.26, pp.3957-3964, 2012. ,
Several HLA alleles share overlapping peptide specificities, J Immunol, vol.154, issue.1, pp.247-259, 1995. ,
HLA class I supertypes: a revised and updated classification, BMC Immunol, vol.9, p.1, 2008. ,
, Combination of In Silico Methods in the Search for Potential CD4(+) and CD8(+) T Cell Epitopes in the Proteome of Leishmania braziliensis, vol.7, p.327, 2016.
Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review, Mem Inst Oswaldo Cruz, vol.99, issue.3, pp.239-251, 2004. ,
Development of miltefosine as an oral treatment for leishmaniasis, Trans R Soc Trop Med Hyg, vol.100, pp.17-20, 2006. ,
Leishmaniasis: vaccine candidates and perspectives, Vaccine, vol.30, issue.26, pp.3834-3842, 2012. ,
,
Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood, Clin Vaccine Immunol, vol.19, issue.6, pp.961-966, 2012. ,
Whole blood assay and visceral leishmaniasis: Challenges and promises, Immunobiology, vol.219, issue.4, pp.323-328, 2014. ,
Peptide-based synthetic vaccines, Chem Sci, vol.7, issue.2, pp.842-854, 2016. ,
Editorial: Measurement of delayed skin-test responses, N Engl J Med, vol.293, issue.10, pp.501-502, 1975. ,
Modulation of dendritic cell function by Leishmania parasites, J Immunol, vol.180, issue.7, pp.4355-4360, 2008. ,
American tegumentary leishmaniasis: cytokines and nitric oxide in active disease and after clinical cure, with or without chemotherapy, Scand J Immunol, vol.76, issue.2, pp.175-180, 2012. ,
The history of leishmaniasis, Parasit Vectors, vol.10, issue.1, p.82, 2017. ,
The classification of amino acid conservation, J Theor Biol, vol.119, issue.2, pp.205-218, 1986. ,
Leukocytes infiltrate the skin and draining lymph nodes in response to the protozoan Leishmania infantum chagasi, Infect Immun, vol.79, issue.1, pp.108-117, 2011. ,
Recent Advances in Vaccines Against Leishmania Based on Patent Applications, Recent Pat Biotechnol, vol.12, issue.1, pp.21-32, 2018. ,
Monophyletic origin of the genus Leishmania Ross, Ann Parasitol Hum Comp, vol.68, issue.2, pp.107-108, 1903. ,
The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent and distal priming, Immunology, vol.128, issue.1, pp.83-91, 2009. ,
Mature dendritic cells are superior to immature dendritic cells in expanding antigen-specific naive and memory CD8+ T cells, Anticancer Res, vol.24, issue.5C, pp.3327-3333, 2004. ,
Leishmaniasis: a review, F1000Res, vol.6, p.750, 2017. ,
Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules, J Immunol, vol.169, issue.9, pp.4961-4969, 2002. ,
Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells, J Exp Med, vol.199, issue.11, pp.1559-1566, 2004. ,
Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease, J Immunol, vol.167, issue.12, pp.6967-6974, 2001. ,
Emergence of a CD4+CD28-granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection, J Immunol, vol.173, issue.3, pp.1834-1841, 2004. ,
,
Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages, J Immunol, vol.173, issue.11, pp.6521-6525, 2004. ,
Safety and immunogenicity of a killed Leishmania (L.) amazonensis vaccine against cutaneous leishmaniasis in Colombia: a randomized controlled trial, Trans R Soc Trop Med Hyg, vol.94, issue.6, pp.698-703, 2000. ,
Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis, PLoS One, vol.5, issue.4, p.10107, 2010. ,
Immuno-informatics based approaches to identify CD8+ T cell epitopes within the Leishmania donovani 3-ectonucleotidase in cured visceral leishmaniasis subjects, Microbes Infect, vol.19, issue.6, pp.358-369, 2017. ,
Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity, J Exp Med, vol.188, issue.8, pp.1547-1552, 1998. ,
Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis, J Immunol, vol.161, issue.10, pp.5284-5295, 1998. ,
Screening and identification of novel B cell epitopes of Toxoplasma gondii SAG1, Parasit Vectors, vol.6, p.125, 2013. ,
A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study, Breast Cancer Res Treat, vol.119, issue.3, pp.673-683, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00535420
Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF, J Immunol, vol.166, issue.6, pp.4012-4019, 2001. ,
Human leukocyte antigen gene polymorphism and the histocompatibility laboratory, J Mol Diagn, vol.3, issue.3, pp.98-104, 2001. ,
Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity, J Exp Med, vol.203, issue.1, pp.177-188, 2006. ,
Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells, Nat Protoc, vol.9, issue.4, pp.950-966, 2014. ,
,
Vaccines for the leishmaniases: proposals for a research agenda, PLoS Negl Trop Dis, vol.5, issue.3, p.943, 2011. ,
Rapid identification of Leishmania complexes by a real-time PCR assay, Am J Trop Med Hyg, vol.73, issue.6, pp.999-1004, 2005. ,
Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo, Nat Immunol, vol.3, issue.9, pp.852-858, 2002. ,
A live Leishmania major vaccine containing CpG motifs induces the de novo generation of Th17 cells in C57BL/6 mice, Eur J Immunol, vol.40, issue.9, pp.2517-2527, 2010. ,
CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice, J Immunol, vol.170, issue.1, pp.394-399, 2003. ,
Identification and characterization of host-protective T-cell epitopes of a major surface glycoprotein (gp63) from Leishmania major, Immunology, vol.72, issue.1, pp.3-9, 1991. ,
Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites, Nat Med, vol.10, issue.10, pp.1104-1110, 2004. ,